Related Experiment Videos
Thigmotaxis as a test for anxiolytic activity in rats
1University of Alberta, Edmonton, Canada.
Pharmacology, Biochemistry, and Behavior
|December 1, 1988
Summary
Thigmotaxis, or the tendency to stay near walls, can be suppressed by anxiolytic drugs. This behavioral assay shows promise for identifying anti-anxiety medications.
Area of Science:
- Neuroscience
- Behavioral Pharmacology
Background:
- Phylogenetically prepared fear reactions are proposed as behavioral assays for anxiolytic agents.
- Thigmotaxis in rodents is a natural behavior that can be modified by anxiolytic drugs.
Purpose of the Study:
- To evaluate thigmotaxis as a behavioral assay for anxiolytic activity.
- To assess the drug-class specificity of the anxiolytic effects on thigmotaxis.
Main Methods:
- Rats were administered anxiolytic agents (diazepam, chlordiazepoxide, pentobarbital) and their thigmotactic behavior was measured.
- Analysis of covariance was used to control for general activity effects.
- Non-anxiolytic drugs (d-amphetamine, morphine, chlorpromazine) were also tested.
Main Results:
- Anxiolytic agents dose-dependently suppressed thigmotaxis, with relative potencies mirroring human anxiolytic treatment.
- After controlling for general activity, the anti-thigmotaxic effect demonstrated drug-class specificity.
- d-amphetamine, morphine, and chlorpromazine did not produce anti-thigmotaxic effects.
Conclusions:
- Thigmotaxis suppression by anxiolytic agents suggests its utility as a behavioral assay for anxiolytic activity.
- The test exhibits a degree of specificity for anxiolytic drugs, supporting its validity.
- This study reinforces previous findings on the usefulness of thigmotaxis as an anxiolytic test in rats.